Dr. Crawford is an internationally recognized expert in prostate cancer, benign prostate hypertrophy (BPH) and other urologic cancers.
Dr. Crawford is the distinguished Professor of Surgery, Urology, and Radiation Oncology, and head of the Section of Urologic Oncology at the University of Colorado Anschutz Medical Campus. He is an active clinician, researcher, and teacher. He has been recognized as one of the Best Doctors in America, one of the Best Cancer Doctors, one of the Top 20 Urologists in the county by Men's Health Magazine, and recently selected as the Healthcare Provider of the Year in the Denver Metro Area by The Denver Business Journal. In addition, he is the recipient of more than 95 research grants in the diagnosis and treatment of prostate cancer, metastatic prostate cancer, hormone refractory prostate cancer, benign prostatic hyperplasia (BPH), advanced bladder cancer, and other areas of urological infections and malignancies. He has authored or coauthored over 600 published articles, contributed to nearly 100 educational books and provided thousands of educational talks for patients and physicians. In an effort to raise awareness and education about prostate health, Dr. Crawford also founded and chairs a 501c3 non-profit called the Prostate Conditions Education Council.
Targeted Focal Therapy ("The Male Lumpectomy")
The next generation in prostate cancer treatment designed to cure the cancer while preserving a patient’s quality of life by minimizing side effects. Targeted Focal Therapy is a new approach for managment of early stage, organ-confined prostate cancer. It involves eradicating only the areas of cancer within the prostate and sparing the rest of the prostate. The rationale behind this approach is to preserve quality of life by minimizing collateral damage to the vital structures around the prostate. Utilized in conjunction with 3D Staging Biopsy, which allows us to find the exact location of cancer within the prostate, we can target and treat only the areas of cancer. Learn more.
Dr. Crawford was awarded the 2012 Robert Krane Prize for best clinical paper in the British Journal of Urology Learn more.
Dr. Crawford responds to the United States Preventitive Services Task Force recommendation on prostate cancer screening Learn more.
Dr. Crawford speaks about new classes of drugs that target androgens in novel ways: New drugs, new ways to target androgens in prostate cancer therapy
Dr. Crawford discusses active surveillance vs surgery in his article, Okay to go Slow with Prostate Cancer- Daily Rx
Dr. Crawford discusses the role of Finasteride and Dutasteride in diagnosing prostate cancer in his article, Solving Prostate Cancer Dillema- Daily Rx
Dr. Crawford is recognized by the Yampa Valley Medical Center Learn more.
Dr. Crawford is discusses the FDA approval of Xtandi as a New Weapon in Widening the War on Prostate Cancer Learn more.
Dr. Crawford discusses heart risk factors tied to cancer survival Learn more.
Dr. Crawford discusses a new web tool to track or treat prostate cancer Learn more.
Dr. Crawford discusses Zytiga as a new option for late stage prostate cancer Learn more.
Dr. Crawford discusses how aggressive prostate cancer may be more accurately found through changes in PSA levels Learn more.
Dr. Crawford discusses the link between urinary tract cancers and hematuria risk Learn more.
Dr. Crawford discusses how cancer cases and deaths in US is estimated to increase in 2013 Learn more.
Dr. Crawford discusses how prostate cancer risks may be reduced with exercise in white but not black men Learn more.
Dr. Crawford discusses the link between prostate cancer and Lynch syndrome Learn more.
Dr. Crawford discusses how prostate cancer surveillance criteria may be different based on race Learn more.
Dr. Crawford discusses how prostate cancer risk in black men may be associated with early frontal baldness Learn more.
Dr. Crawford discusses the long term survival rates of radiation vs. surgery for prostate cancer Learn more.
Dr. Crawford discusses how intermittent androgen deprivation therapy is not as powerful as continuous therapy in recurrent prostate cancer Learn more.
Dr. Crawford discusses how older men are less susceptible to die of prostate cancer Learn more.
Dr. Crawford discusses how patients who drank more coffee had lower prostate cancer recurrence rates Learn more.
The University of Colorado discusses Dr. Crawford's role in accurately diagnosing prostate cancer through 3 Dimensional Mapping Biopsy Learn more.
Dr. Crawford discusses the United States Preventive Services Task Force (USPSTF) recommendation against PSA screening Learn more.